Prodotti competitors / Area HIV
Raltegravir Viatris: Withdrawal of the marketing authorisation application
![Immagine News](/media/l4el5htd/cat-2.jpg?anchor=center&mode=crop&width=722&height=442)
The company Viatris withdrew its application for a marketing authorisation of Raltegravir Viatris for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.The company withdrew the application on 22 February 2023
Link news: https://www.ema.europa.eu/en/medicines/human/withdrawn-applications/raltegravir-viatris
Grazie per il tuo feedback!